GlassScriptPhysician profile
Kristopher J Selke
NPI 1376747733
$4,069.27
in general payments reported to CMS, 2019-2025
8 companies · $1,913 in 2025
The $1,913 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,305 · 2020: $14.39 · 2021: $335 · 2022: $168 · 2023: $55.91 · 2024: $279 · 2025: $1,913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,364 · Food and Beverage: $884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,363.61 |
| Food and Beverage | $883.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,138.36 | 2019-2025 | Pascal |
| Boston Scientific Corporation | $1,071.37 | 2019-2023 | Watchman Flx |
| Abbott Laboratories | $524.32 | 2021-2025 | Amplatzer, Amplatzer Amulet |
| Medtronic, INC. | $178.04 | 2021-2024 | Onyx Frontier |
| Astrazeneca Pharmaceuticals LP | $104.56 | 2021-2022 | |
| Lundbeck LLC | $18.25 | 2019 | |
| Cardiva Medical, INC. | $17.77 | 2024 | Optowire |
| Janssen Pharmaceuticals, INC | $16.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristopher Selke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.